BCRXBioCryst Pharmaceuticals
Smart Score
How it is scored →The Smart Score (1–10) describes how this instrument compares with its peers on published, rules-based measures of value, quality, trend, stability and dividend safety. It is not a forecast and not personal advice.
Compared with: Health care companies in USA (n = 211)
Current rating first published: · last recomputed · rating log
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- Gross profit growth / assets (5 y)supports the score · percentile 98
- Share issuance (1 y)weighs on the score · percentile 9
- Accrualssupports the score · percentile 100
Red flags and notes
- Caution:Cash burn Negative free cash flow in at least two of the last three years.
- Caution:Dilution Share count growing 3–10 % a year over three years.
- Caution:High leverage Net debt above 4× EBITDA or interest cover below 2×.
- Caution:Negative equity Book equity is below zero.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- P/S
- 2,2
- Free-cash-flow yield
- 18,2 %
- Market cap (EUR)
- 1,8 Mrd. €
Profitability and debt
- Gross margin
- 97,8 %
Dividends
- Dividend yield
- 0,00 %
- Years of dividend growth
- 0
Returns and risk
- 1 day
- −0,2 %
- 1 month
- −2,2 %
- 1 year
- +25,4 %
- Volatility, 1 yr
- 47,3 %
- Max drawdown, 1 yr
- −28,4 %
- Beta
- 0,75
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
News and filings
- BIOCRYST PHARMACEUTICALS INC: 10-Q — Quarterly report for the period ending 2026-06-30
FactSEC EDGAR · Filing · 5 Aug. 2026
- BIOCRYST PHARMACEUTICALS INC: 8-K — Results of operations; Regulation FD disclosure
FactSEC EDGAR · Filing · 5 Aug. 2026
- BIOCRYST PHARMACEUTICALS INC: 8-K/A (amendment) — Exit or disposal costs
FactSEC EDGAR · Filing · 4 Aug. 2026
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| First rating | 3/10 | 2 · — | Caution:Cash burnCaution:DilutionCaution:High leverageCaution:Negative equity | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Hier aus Vertrag aussteigen · EU-Verbraucher: 14 Tage Widerrufsrecht bei Käufen.